The Conversation (0)
Chart
Detailed Quote
Microbix develops proprietary biological technology solutions for human health and well-being, with about 90 skilled employees and sales growing from a base of over $1 million per month. It makes a wide range of critical biological materials for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products that support clinical lab proficiency testing, assay development and validation, or clinical lab workflows.
Featured Articles and Interviews
Apr 22, 2025
Top 5 Canadian Biotech Stocks (Updated April 2025)
Press Releases
May 14, 2026
Microbix Reports Results for H1 & Q2 2026
See More Press Releases
Alert Options
No alert set
INN Article Notification
Alert Option
You will be notified when this event occurs. No additional settings needed.
